--- title: "Weekly Recap | Avantor +2.67%, outperforming the S&P 500" type: "News" locale: "en" url: "https://longbridge.com/en/news/298095565.md" description: "Avantor (AVTR) rose 2.67% on the week to close at $14.97, outperforming the S&P 500 by about 2.58 percentage points. The week started soft, with Monday and Tuesday trading between $14.19 and $14.63. The stock firmed from Wednesday, spiked to a weekly high of $15.20 on Thursday and closed at $15.19, before slipping to $14.97 on Friday. Weekly amplitude was 6.95%. Average daily volume of about 7.62m shares sat roughly 3.65% below its 60-day median, a muted turnover." datetime: "2026-09-05T06:09:49.000Z" locales: - [zh-CN](https://longbridge.com/zh-CN/news/298095565.md) - [en](https://longbridge.com/en/news/298095565.md) - [zh-HK](https://longbridge.com/zh-HK/news/298095565.md) generator: "portal-rs" --- # Weekly Recap | Avantor +2.67%, outperforming the S&P 500 ## The Week Avantor (AVTR) rose 2.67% on the week to close at $14.97, outperforming the S&P 500 by about 2.58 percentage points. The week started soft, with Monday and Tuesday trading between $14.19 and $14.63. The stock firmed from Wednesday, spiked to a weekly high of $15.20 on Thursday and closed at $15.19, before slipping to $14.97 on Friday. Weekly amplitude was 6.95%. Average daily volume of about 7.62m shares sat roughly 3.65% below its 60-day median, a muted turnover. There were no major company-specific catalysts this week. ## Analyst Ratings 16 brokers cover the stock: 3 strong buy, 1 under, and the remaining 12 hold. The consensus rating is hold, with a consensus target of $14.56, about 2.71% below the latest price. Targets range from $12.00 to $19.00, pointing to wide dispersion. Within the life sciences tools and services industry, Avantor ranks 13th out of 54 names based on analyst coverage. ## The Week Ahead The macro calendar is busier next week. Tuesday brings the NFIB small business optimism index, while Thursday sees the 10-year Treasury auction, initial jobless claims, final demand PPI and existing home sales. Treasury yield moves could shift risk appetite across growth and life sciences names, so watch whether Avantor tracks any sector-wide swings. The broader life sciences tools complex is worth monitoring to see if the stock can build on this week’s mild recovery. *This article is generated by LongbridgeAI from market data, for information only and not investment advice.* ### Related Stocks - [AVTR.US](https://longbridge.com/en/quote/AVTR.US.md) ## Related News & Research - [Avantor EVP, CFO Todd Garner files initial beneficial ownership statement (Form 3)](https://longbridge.com/en/news/299940394.md) - [Avantor: New CFO Brings Stability as Revival Turnaround Progress Keeps Risk‑Reward Balanced, Analyst Reiterates Hold](https://longbridge.com/en/news/299657793.md) - [Avantor Expands RIM Single-Use Portfolio Across APAC](https://longbridge.com/en/news/299256553.md) - [Nvidia's record buyback shows chipmaker's stock is too cheap for CEO Huang to resist](https://longbridge.com/en/news/300425901.md) - [NVDA or AMD: Cathie Wood Buys $78.8M of One AI Stock Today, Sells the Other](https://longbridge.com/en/news/300500578.md) --- > **Disclaimer: This article is for reference only and does not constitute any investment advice.**